Loading...
Indian Pharmaceutical Exporter · #1 for Cefixime · $19.1M export value · DGFT Verified
Micro Labs Limited is the #1 Indian exporter of Cefixime with $19.1M in export value and 697 verified shipments. Micro Labs Limited holds a 11.0% market share in Cefixime exports across 25 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
| $1.1M |
| 82 |
| 7.7% |
| RWANDA | $761.3K | 57 | 5.4% |
| UGANDA | $707.8K | 30 | 5.0% |
| NIGERIA | $697.9K | 30 | 4.9% |
| MAURITIUS | $696.8K | 51 | 4.9% |
| NETHERLANDS | $501.3K | 19 | 3.5% |
Micro Labs Limited exports Cefixime to 28 countries. The largest destination is JORDAN accounting for 21.9% of Micro Labs Limited's Cefixime shipments, followed by FRANCE (12.6%) and IRAQ (11.7%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $3.1M | 74 |
| AL KAWKAB SCIENTIFIC BUREAU | JORDAN | $1.5M | 31 |
| LABOREX UGANDA LIMITED | KENYA | $1.4M | 66 |
| E.P.DIS | FRANCE | $1.1M | 54 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $632.6K | 28 |
| SOMAPHAR | MADAGASCAR | $494.4K | 38 |
| FTM (MAURITIUS) LIMITED | MAURITIUS | $491.3K | 31 |
| NUTRI-PHARMA USA COMPANY LIMITED | VIETNAM | $439.3K | 12 |
| HATAY PHARMACEUTICAL JOINT STOCK | VIETNAM, DEMOCRATIC REP. OF | $413.6K | 10 |
| HAWKARY PHARMACEUTICAL COMPANY# | IRAQ | $351.8K | 9 |
Micro Labs Limited supplies Cefixime to 71 buyers globally. The largest buyer is AL-KAWKAB SCIENTIFIC BUREAU (JORDAN), followed by AL KAWKAB SCIENTIFIC BUREAU (JORDAN) and LABOREX UGANDA LIMITED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $61.9M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. Micro Labs Limited contributes $19.1M to this total, accounting for 11.0% of India's Cefixime exports. Micro Labs Limited ships Cefixime to 28 countries through 71 buyers.
Micro Labs Limited's average Cefixime shipment value is $27.4K per consignment, based on 697 shipments totaling $19.1M. The largest destination is JORDAN (21.9% of Micro Labs Limited's Cefixime exports).
Micro Labs Limited ranks #1 among 668 Indian Cefixime exporters with a 11.0% market share. The top 3 exporters are MICRO LABS LIMITED ($19.1M), AUROBINDO PHARMA LTD ($8.0M), SAKAR HEALTHCARE LIMITED ($4.5M). Micro Labs Limited processed 697 shipments to 25 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GRAMOCEF-O-200 (CEFIXIME 200MG CAPSULES) | $206.4K | 11 |
| SUPIXIME-100 DRY SYRUP(CEFIXIME FOR ORAL | $200.0K | 4 |
| MYROKEN-200 (CEFIXIME CAPSULES 200MG) (1 | $200.0K | 4 |
| SUPIXIME-100 DRY SYRUP (CEFIXIME FOR ORA | $200.0K | 4 |
| SUPIXIME 100 DRY SYRUP CEFIXIME FOR ORAL SUSPENSION USP 100MG 60 ML QTY 98010 00 FAC INV 707201861 | $200.0K | 4 |
| SUPIXIME 100 DRY SYRUP CEFIXIME FOR ORALSUSPENSION USP 100MG 60 ML QTY 98184 00 FAC 707201859 | $150.0K | 3 |
| GRAMOCEF-O-100 DRY SYRUP ( (Cefixime for | $137.5K | 6 |
| GRAMOCEF O 50 DRY SYRUP ( (Cefixime for | $122.8K | 7 |
| GRAMOCEF-O-200 ( (Cefixime 200mg Capsule | $115.8K | 8 |
| GRAMOCEF-O-100 DRY SYRUP (CEFIXIME FOR O | $113.9K | 7 |
Micro Labs Limited exports 539 distinct Cefixime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GRAMOCEF-O-200 (CEFIXIME 200MG CAPSULES) with 11 shipments worth $206.4K.
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MICRO LABS LIMITED ★ | $19.1M | 697 | 25 | $27.4K |
| 3 | AUROBINDO PHARMA LTD | $8.0M | 192 | 6 | $41.6K |
| 5 | SAKAR HEALTHCARE LIMITED | $4.5M | 91 | 11 | $50.0K |
Micro Labs Limited ranks #1 among 668 Indian Cefixime exporters. Average shipment value of $27.4K compared to the market average of $92.6K. The closest competitors by value are AUROBINDO PHARMA LTD and SAKAR HEALTHCARE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 924 | 11.0% |
| JNPT | 498 | 5.9% |
| JNPT/ NHAVA SHEVA SEA | 480 | 5.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 449 | 5.3% |
| SAHAR AIR | 412 | 4.9% |
| DELHI AIR CARGO ACC (INDEL4) | 399 | 4.8% |
| DELHI AIR | 366 | 4.4% |
| AHEMDABAD ICD | 226 | 2.7% |
Micro Labs Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Visual overview of India's cefixime supplier profile for Micro Labs Limited — top suppliers, destinations, pricing, and trade routes
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
Micro Labs Limited exports 76 products worth $463.6M. Beyond Cefixime, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Cefixime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current shipment-level data, contact TransData Nexus.